-
1Academic Journal
المؤلفون: Alkan, Hakan, Keskin, YaÅŸar, Nas, Kemal, Kılıç, Erkan, Sargın, Betül, Acer Kasman, Sevtap, Åžahin, Nilay, Ataman, Åžebnem, Figen, Ayhan F., Gök, Kevser, TekeoÄŸlu, Ä°brahim, Duruöz, Mehmet Tuncay, KüçükakkaÅŸ, Okan, Yurdakul, Ozan Volkan, Alkan MelikoÄŸlu, Meltem, Bodur, Hatice, Cengiz, Gizem, Cüzdan, Nihan, Albayrak Gezer, Ä°lknur, Keskin, Dilek, MülkoÄŸlu, Cevriye, Resorlu, Hatice, Bal, Ajda, Aydın, Yıldıray, Çalış, Mustafa, Çapkın, Erhan, Devrimsel, Gül, Hizmetli, Sami, Kamanlı, Ayhan, Ecesoy, Hilal, Kutluk, Öznur, Åžen, Nesrin, Åžendur, Ömer Faruk, Tolu, Sena, Toprak, Murat, Tuncer, Tiraje
مصطلحات موضوعية: hydroxychloroquine, infliximab, golimumab, leflunomide, Disease-modifying antirheumatic drug, Functional status, Psoriatic arthritis, Quality of life, adalimumab, biological disease modifying antirheumatic drug, certolizumab pegol, conventional synthetic disease modifying antirheumatic drug, cyclosporine, disease modifying antirheumatic drug, etanercept, methotrexate, salazosulfapyridine, secukinumab, unclassified drug, ustekinumab, adult, aged, Article, Bath ankylosing spondylitis disease activity index, Bath ankylosing spondylitis functional index, body mass, clinical feature, cohort analysis, cross-sectional study, DAS28
Relation: Archives of Rheumatology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.46497/ArchRheumatol.2021.7874; https://search.trdizin.gov.tr/yayin/detay/465392; https://hdl.handle.net/11499/47821; 36
-
2Academic Journal
المؤلفون: Rieke Alten, Harald Burkhardt, Eugen Feist, Klaus Krüger, Juergen Rech, Andrea Rubbert-Roth, Reinhard E. Voll, Yedid Elbez, Christiane Rauch
المصدر: Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)
مصطلحات موضوعية: Abatacept, Conventional synthetic disease-modifying antirheumatic drug, Azathioprine, Hydroxychloroquine, Leflunomide, Methotrexate, Diseases of the musculoskeletal system, RC925-935
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: Daisuke Kobayashi, Eriko Hasegawa, Hajime Ishikawa, Ichiei Narita, Satoshi Ito, 伊藤 聡, 小林 大介, 成田 一衛, 石川 肇, 長谷川 絵理子
المصدر: 臨床リウマチ / Clinical Rheumatology and Related Research. 2019, 31(2):145
-
4
المؤلفون: Şebnem Ataman, Erkan Kilic, Okan Küçükakkaş, Gul Devrimsel, Nihan Cuzdan, Ayhan Kamanli, Yaşar Keskin, Tiraje Tuncer, Ilknur Albayrak Gezer, Gizem Cengiz, Hatice Bodur, Cevriye Mülkoğlu, Hatice Reşorlu, Nilay Sahin, Oznur Kutluk, Mustafa Çaliş, Mehmet Tuncay Duruöz, Murat Toprak, Sevtap Acer Kasman, Hakan Alkan, Betul Sargin, Ömer Faruk Şendur, Dilek Keskin, Hilal Ecesoy, Ozan Volkan Yurdakul, İbrahim Tekeoğlu, Sena Tolu, Erhan Capkin, Meltem Alkan Melikoglu, Sami Hizmetli, Figen Ayhan, Nesrin Şen, Kevser Gok, Ajda Bal, Kemal Nas, Yildiray Aydin
المساهمون: Tıp Fakültesi, RTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Devrimsel, Gül
المصدر: Archives of Rheumatology
مصطلحات موضوعية: Bath ankylosing spondylitis disease activity index, medicine.medical_treatment, tender joint count, swollen joint count, Psoriasis Area and Severity Index, 0302 clinical medicine, Quality of life, adalimumab, disease modifying antirheumatic drug, Health Assessment Questionnaire, 030212 general & internal medicine, golimumab, BASDAI, Disease-Modifying Antirheumatic Drug, conventional synthetic disease modifying antirheumatic drug, secukinumab, adult, cohort analysis, unclassified drug, aged, patient assessment, Psoriatic Arthritis Quality of Life, female, biological disease modifying antirheumatic drug, monotherapy, Psoriatic arthritis, Original Article, medicine.medical_specialty, hydroxychloroquine, Visual analogue scale, Psoriatic Arthritis, salazosulfapyridine, methotrexate, ustekinumab, Article, 03 medical and health sciences, male, Rheumatology, Internal medicine, medicine, cross-sectional study, DAS28, cyclosporine, human, Disease-modifying antirheumatic drug, leflunomide, 030203 arthritis & rheumatology, Functional Assessment of Chronic Illness Therapy, Ankylosing spondylitis, business.industry, visual analog scale, social interaction, Functional status, medicine.disease, major clinical study, body mass, clinical feature, certolizumab pegol, Functional Status, Short Form 36, Bath ankylosing spondylitis functional index, Quality of Life, infliximab, business, etanercept, disease activity
وصف الملف: application/pdf
-
5
المؤلفون: Reinhard E. Voll, Eugen Feist, Harald Burkhardt, C. Rauch, Rieke Alten, Juergen Rech, Yedid Elbez, Andrea Rubbert-Roth, Klaus Krüger
المصدر: Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)
Arthritis Research & Therapyمصطلحات موضوعية: 0301 basic medicine, Adult, Male, musculoskeletal diseases, medicine.medical_specialty, lcsh:Diseases of the musculoskeletal system, Azathioprine, Arthritis, Rheumatoid, Abatacept, 03 medical and health sciences, Disability Evaluation, 0302 clinical medicine, Sulfasalazine, Medizinische Fakultät, Internal medicine, Surveys and Questionnaires, Conventional synthetic disease-modifying antirheumatic drug, medicine, Humans, ddc:610, Rheumatoid arthritis, Adverse effect, skin and connective tissue diseases, Leflunomide, Aged, 030203 arthritis & rheumatology, Clinical Trials as Topic, business.industry, Hydroxychloroquine, Middle Aged, medicine.disease, 030104 developmental biology, Treatment Outcome, Methotrexate, Antirheumatic Agents, Drug Therapy, Combination, Female, lcsh:RC925-935, business, medicine.drug, Research Article
وصف الملف: application/octet-stream; application/pdf